Akizawa, T., Shimazaki, R., Shiramoto, M., & Fukagawa, M. (2019). Response to Comments on “Pharmacokinetics, Pharmacodynamics, and Safety of the Novel Calcimimetic Agent Evocalcet in Healthy Japanese Subjects: First-in-Human Phase I Study”. Clin Drug Investig.
Chicago ZitierstilAkizawa, Tadao, Ryutaro Shimazaki, Masanari Shiramoto, und Masafumi Fukagawa. "Response to Comments On “Pharmacokinetics, Pharmacodynamics, and Safety of the Novel Calcimimetic Agent Evocalcet in Healthy Japanese Subjects: First-in-Human Phase I Study”." Clin Drug Investig 2019.
MLA ZitierstilAkizawa, Tadao, Ryutaro Shimazaki, Masanari Shiramoto, und Masafumi Fukagawa. "Response to Comments On “Pharmacokinetics, Pharmacodynamics, and Safety of the Novel Calcimimetic Agent Evocalcet in Healthy Japanese Subjects: First-in-Human Phase I Study”." Clin Drug Investig 2019.